Table 1. Maternal characteristics.
Variables | n (%) | |
---|---|---|
Age (year), mean (SD) | 34 (± 4.7) | |
Period | ||
Pre-delta (Sep 2020 – May 2021) | 1 (1.7) | |
Delta dominant (June 2021 – Jan 2022) | 13 (21.7) | |
Omicron dominant (Feb 2022 – Apr 2022) | 46 (76.7) | |
Gestational age (weeks), mean (SD) | 38+2 (± 2+0) | |
Period between first positive SARS-CoV-2 test and delivery (day), median (IQR) | 1 (0 - 2.3) | |
Birth-related complications | 1 (1.7) | |
Method of delivery | ||
Cesarean section | 40 (66.7) | |
Vaginal delivery | 20 (33.3) | |
Vaccination | ||
Yes | 9 (15.0) | |
No | 33 (55.0) | |
Unknown | 18 (30.0) | |
Underlying disease | ||
Any disease | 9 (15.0) | |
DM | 4 (13.3) | |
Solid cancer | 2 (3.3) | |
Cardiovascular disease | 2 (3.3) | |
HTN | 1 (1.7) | |
Pneumonia | ||
Total | 7 (11.7) | |
Pre Omicron dominant period | 3 (5.0) | |
Omicron dominant period | 4 (6.7) | |
Lymphocyte count, mean (SD) | 1,208 (± 553.5) | |
Lymphocytopenia (<1,000/mcL) | ||
Yes | 16 (26.7) | |
No | 22 (36.7) | |
Unchecked | 22 (36.7) | |
CRP (mg/dL), mean (SD) | 0.94 (± 0.76) | |
Elevated CRP (>0.6 mg/dL) | ||
Yes | 30 (50.0) | |
No | 27 (45.0) | |
Unchecked | 3 (5.0) | |
Elevated LD (>250 IU/L) | ||
Yes | 16 (56.7) | |
No | 34 (26.7) | |
Unchecked | 10 (16.7) | |
Oxygen supply | 2 (3.3) | |
ICU care | 0 (0.0) | |
Symptom | ||
Any symptom | 37 (61.7) | |
Fever | 18 (70.0) | |
Chill | 6 (10.0) | |
Cough | 21 (35.0) | |
Sputum | 9 (15.0) | |
Sore throat | 13 (21.7) | |
Dyspnea | 3 (5.0) | |
Rhinorrhea | 4 (6.7) | |
Myalgia | 6 (10.0) | |
Headache | 7 (11.7) | |
Nasal congestion | 3 (5.0) | |
Hyposmia | 1 (1.7) | |
Hypogeusia | 1 (1.7) | |
Severity | ||
Asymptomatic | 23 (38.3) | |
Mild illness | 25 (41.7) | |
Moderate illness | 10 (26.1) | |
Severe illness | 2 (5.2) | |
Critical illness | 0 (0.0) | |
Treatment | ||
Regdanvimab | 10 (16.7) | |
Dexamethasone | 1 (1.7) | |
Remdesivir | 1 (1.7) | |
Mechanical ventilation | 0 (0.0) | |
In hospital mortality | 0 (0.0) |
SD, standard deviation; SARS-CoV-2, severe acute respiratory syndrome corona virus 2;
IQR, Interquatile range; DM, diabetes mellitus; HTN, hypertension; CRP, C-Reactive Protein; LD, Lactate Dehydrogenase; ICU, intensive care unit.